302440 — SK Bioscience Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeLarge CapFalling Star

Annual cashflow statement for SK Bioscience Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	14,677	32,890	355,139	122,452	22,318
Depreciation
Amortisation
Non-Cash Items	11,184	8,612	130,619	36,221	7,969
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-4,432	62,195	32,060	-310,868	-35,705
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	35,973	120,224	536,594	-124,958	29,346
Capital Expenditures	-23,968	-10,198	-44,470	-76,489	-50,295
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	21,322	-97,895	-1,377,471	349,136	5,017
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-2,646	-108,093	-1,421,940	272,647	-45,279
Financing Cash Flow Items	—	-301	-628	—	5,484
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-23,435	-1,539	958,380	-19,867	-89,583
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	9,891	10,592	73,056	127,259	-98,262